Cancers (Feb 2022)

Stereotactic Body Radiation Therapy in Patients with Oligometastatic Disease: Clinical State of the Art and Perspectives

  • Rémy Kinj,
  • Emilien Muggeo,
  • Luis Schiappacasse,
  • Jean Bourhis,
  • Fernanda G. Herrera

DOI
https://doi.org/10.3390/cancers14051152
Journal volume & issue
Vol. 14, no. 5
p. 1152

Abstract

Read online

Stereotactic body radiation therapy (SBRT) is a form of radiation therapy (RT) in which a small number of high doses of radiation are delivered to a target volume using highly sophisticated equipment. Stereotactic body radiation therapy is crucial in two cancer stages: early primary cancer and oligometastatic disease, with the goal of inducing complete cancer remission in both. This treatment method is commonly used to treat a variety of disease types. Over the years, a growing body of clinical evidence on the use of SBRT for the treatment of primary and metastatic tumors has accumulated, with efficacy and safety demonstrated in randomized clinical trials. This article will review the technical and clinical aspects of SBRT according to disease type and clinical indication.

Keywords